Serum Withdrawal-Induced Accumulation of Phosphoinositide 3-Kinase Lipids in Differentiating 3T3-L6 Myoblasts: Distinct Roles for Ship2 and PTEN

REFERENCES

• Alessi, D. R., S. R. James, C. P. Downes, A. B. Holmes, P. R. Gaffney, C. B. Reese, and P. Cohen. 1997. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 7:261–269.
   PubMed Web of Science ®Google Scholar
• Blero, D., J. Zhang, X. Pesesse, B. Payrastre, J. E. Dumont, S. Shurmans, and C. Erneux. 2005. Phosphatidylinositol 3,4,5-trisphosphate modulation in Ship2 deficient mouse embryonic fibroblast. FEBS J. 272:2512–2522.
   PubMedGoogle Scholar
• Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Cantley, L. C. 2002. The phosphoinositide 3-kinase pathway. Science 296:1655–1657.
   PubMed Web of Science ®Google Scholar
• Clement, S., U. Krause, F. Desmedt, J. F. Tanti, J. Behrends, X. Pesesse, T. Sasaki, J. Penninger, M. Doherty, W. Malaisse, J. E. Dumont, Y. Le Marchand-Brustel, C. Erneux, L. Hue, and S. Schurmans. 2001. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409:92–97.
   PubMed Web of Science ®Google Scholar
• Coolican, S. A., D. S. Samuel, D. Z. Ewton, F. J. McWade, and J. R. Florini. 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272:6653–6662.
   PubMed Web of Science ®Google Scholar
• Downes, C. P., N. R. Leslie, I. H. Batty, and J. van der Kaay. 2007. Metabolic switching of PI3K-dependent lipid signals. Biochem. Soc. Trans. 35:188–192.
   PubMedGoogle Scholar
• Frank, S. R., M. R. Adelstein, and S. H. Hansen. 2006. GIT2 represses Crk- and Rac1-regulated cell spreading and Cdc42-mediated focal adhesion turnover. EMBO J. 25:1848–1859.
   PubMedGoogle Scholar
• Fujio, Y., K. Guo, T. Mano, Y. Mitsuuchi, J. R. Testa, and K. Walsh. 1999. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol. Cell. Biol. 19:5073–5082.
   PubMed Web of Science ®Google Scholar
• Gonzalez, I., G. Tripathi, E. J. Carter, L. J. Cobb, D. A. Salih, F. A. Lovett, C. Holding, and J. M. Pell. 2004. Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis. Mol. Cell. Biol. 24:3607–3622.
   PubMedGoogle Scholar
• Hresko, R. C., and M. Mueckler. 2005. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280:40406–40416.
   PubMed Web of Science ®Google Scholar
• Ijuin, T., and T. Takenawa. 2003. SKIP negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation. Mol. Cell. Biol. 23:1209–1220.
   PubMed Web of Science ®Google Scholar
• Jiang, B. H., M. Aoki, J. Z. Zheng, J. Li, and P. K. Vogt. 1999. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc. Natl. Acad. Sci. USA 96:2077–2081.
   PubMed Web of Science ®Google Scholar
• Jiang, B. H., J. Z. Zheng, and P. K. Vogt. 1998. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proc. Natl. Acad. Sci. USA 95:14179–14183.
   PubMed Web of Science ®Google Scholar
• Jiang, Z. Y., Q. L. Zhou, K. A. Coleman, M. Chouinard, Q. Boese, and M. P. Czech. 2003. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc. Natl. Acad. Sci. USA. 100:7569–7574.
   PubMed Web of Science ®Google Scholar
• Kaliman, P., J. Canicio, P. R. Shepherd, C. A. Beeton, X. Testar, M. Palacin, and A. Zorzano. 1998. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Mol. Endocrinol. 12:66–77.
   PubMedGoogle Scholar
• Kaliman, P., F. Vinals, X. Testar, M. Palacin, and A. Zorzano. 1996. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Chem. 271:19146–19151.
   PubMed Web of Science ®Google Scholar
• King, W. G., M. D. Mattaliano, T. O. Chan, P. N. Tsichlis, and J. S. Brugge. 1997. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. Biol. 17:4406–4418.
   PubMed Web of Science ®Google Scholar
• Leslie, N. R., and C. P. Downes. 2002. PTEN: the down side of PI 3-kinase signalling. Cell. Signal. 14:285–295.
   PubMed Web of Science ®Google Scholar
• Leslie, N. R., and C. P. Downes. 2004. PTEN function: how normal cells control it and tumour cells lose it. Biochem. J. 382:1–11.
   PubMed Web of Science ®Google Scholar
• Martin, D. E., and M. N. Hall. 2005. The expanding TOR signaling network. Curr. Opin. Cell Biol. 17:158–166.
   PubMed Web of Science ®Google Scholar
• Myers, M. P., I. Pass, I. H. Batty, J. Van der Kaay, J. P. Stolarov, B. A. Hemmings, M. H. Wigler, C. P. Downes, and N. K. Tonks. 1998. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA 95:13513–13518.
   PubMed Web of Science ®Google Scholar
• Pesesse, X., C. Moreau, A. L. Drayer, R. Woscholski, P. Parker, and C. Erneux. 1998. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity. FEBS Lett. 437:301–303.
   PubMedGoogle Scholar
• Polak, P., and M. N. Hall. 2006. mTORC2 caught in a SINful Akt. Dev. Cell 11:433–434.
   PubMedGoogle Scholar
• Rameh, L. E., and L. C. Cantley. 1999. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274:8347–8350.
   PubMed Web of Science ®Google Scholar
• Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098–1101.
   PubMed Web of Science ®Google Scholar
• Sasaoka, T., T. Wada, K. Fukui, S. Murakami, H. Ishihara, R. Suzuki, K. Tobe, T. Kadowaki, and M. Kobayashi. 2004. SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes. J. Biol. Chem. 279:14835–14843.
   PubMed Web of Science ®Google Scholar
• Scheid, M. P., M. Huber, J. E. Damen, M. Hughes, V. Kang, P. Neilsen, G. D. Prestwich, G. Krystal, and V. Duronio. 2002. Phosphatidylinositol (3,4,5)P3 is essential but not sufficient for protein kinase B (PKB) activation: phosphatidylinositol (3,4)P2 is required for PKB phosphorylation at Ser-473: studies using cells from SH2-containing inositol-5-phosphatase knockout mice. J. Biol. Chem. 277:9027–9035.
   PubMed Web of Science ®Google Scholar
• Serunian, L. A., K. R. Auger, and L. C. Cantley. 1991. Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation. Methods Enzymol. 198:78–87.
   PubMedGoogle Scholar
• Sharrard, R. M., and N. J. Maitland. 2007. Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines. Cell. Signal. 19:129–138.
   PubMedGoogle Scholar
• Tang, X., A. M. Powelka, N. A. Soriano, M. P. Czech, and A. Guilherme. 2005. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes. J. Biol. Chem. 280:22523–22529.
   PubMed Web of Science ®Google Scholar
• Toker, A. 2000. Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol. Pharmacol. 57:652–658.
   PubMed Web of Science ®Google Scholar
• Tureckova, J., E. M. Wilson, J. L. Cappalonga, and P. Rotwein. 2001. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J. Biol. Chem. 276:39264–39270.
   PubMed Web of Science ®Google Scholar
• Wada, T., T. Sasaoka, M. Funaki, H. Hori, S. Murakami, M. Ishiki, T. Haruta, T. Asano, W. Ogawa, H. Ishihara, and M. Kobayashi. 2001. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity. Mol. Cell. Biol. 21:1633–1646.
   PubMed Web of Science ®Google Scholar
• Wang, J., and K. Walsh. 1996. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273:359–361.
   PubMedGoogle Scholar
• Watton, S. J., and J. Downward. 1999. Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction. Curr. Biol. 9:433–436.
   PubMed Web of Science ®Google Scholar
• Yoeli-Lerner, M., G. K. Yiu, I. Rabinovitz, P. Erhardt, S. Jauliac, and A. Toker. 2005. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell 20:539–550.
   PubMed Web of Science ®Google Scholar